179 related articles for article (PubMed ID: 16007129)
21. Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression.
Chassot AA; Turchi L; Virolle T; Fitsialos G; Batoz M; Deckert M; Dulic V; Meneguzzi G; Buscà R; Ponzio G
Oncogene; 2007 Aug; 26(39):5772-83. PubMed ID: 17404577
[TBL] [Abstract][Full Text] [Related]
22. ICBP90 Regulates MIF Expression, Glucocorticoid Sensitivity, and Apoptosis at the MIF Immune Susceptibility Locus.
Yao J; Leng L; Fu W; Li J; Bronner C; Bucala R
Arthritis Rheumatol; 2021 Oct; 73(10):1931-1942. PubMed ID: 33844457
[TBL] [Abstract][Full Text] [Related]
23. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
Mann DJ; Jones NC
Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
[TBL] [Abstract][Full Text] [Related]
24. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F.
Chew YP; Ellis M; Wilkie S; Mittnacht S
Oncogene; 1998 Oct; 17(17):2177-86. PubMed ID: 9811449
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic modulation of estrogen receptor-alpha by pRb family proteins: a novel mechanism in breast cancer.
Macaluso M; Montanari M; Noto PB; Gregorio V; Bronner C; Giordano A
Cancer Res; 2007 Aug; 67(16):7731-7. PubMed ID: 17699777
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional activation of tobacco E2F is repressed by co-transfection with the retinoblastoma-related protein: cyclin D expression overcomes this repressor activity.
Uemukai K; Iwakawa H; Kosugi S; de Uemukai S; Kato K; Kondorosi E; Murray JA; Ito M; Shinmyo A; Sekine M
Plant Mol Biol; 2005 Jan; 57(1):83-100. PubMed ID: 15821870
[TBL] [Abstract][Full Text] [Related]
27. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry.
Lomazzi M; Moroni MC; Jensen MR; Frittoli E; Helin K
Nat Genet; 2002 Jun; 31(2):190-4. PubMed ID: 11992123
[TBL] [Abstract][Full Text] [Related]
28. The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation.
Hertel L; Rolle S; De Andrea M; Azzimonti B; Osello R; Gribaudo G; Gariglio M; Landolfo S
Oncogene; 2000 Jul; 19(32):3598-608. PubMed ID: 10951565
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor pRB functions as a co-repressor of the CCAAT displacement protein (CDP/cut) to regulate cell cycle controlled histone H4 transcription.
Gupta S; Luong MX; Bleuming SA; Miele A; Luong M; Young D; Knudsen ES; Van Wijnen AJ; Stein JL; Stein GS
J Cell Physiol; 2003 Sep; 196(3):541-56. PubMed ID: 12891711
[TBL] [Abstract][Full Text] [Related]
30. Early phosphorylation of the retinoblastoma gene product regulates protein binding to the c-fos retinoblastoma control element during T cell activation.
Felzien LK; Branden MG; Benedict SH
Mol Immunol; 1997 May; 34(7):507-17. PubMed ID: 9364216
[TBL] [Abstract][Full Text] [Related]
31. Analysis of sequence-specific binding activity of cis-elements in human thymidine kinase gene promoter during G1/S phase transition.
Good L; Chen J; Chen KY
J Cell Physiol; 1995 Jun; 163(3):636-44. PubMed ID: 7775606
[TBL] [Abstract][Full Text] [Related]
32. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
[TBL] [Abstract][Full Text] [Related]
33. Modulating ICBP90 to suppress human ribonucleotide reductase M2 induction restores sensitivity to hydroxyurea cytotoxicity.
Un F; Qi C; Prosser M; Wang N; Zhou B; Bronner C; Yen Y
Anticancer Res; 2006; 26(4B):2761-7. PubMed ID: 16886595
[TBL] [Abstract][Full Text] [Related]
34. Transcription factors and the down-regulation of G1/S boundary genes in human diploid fibroblasts during senescence.
Chen KY
Front Biosci; 1997 Sep; 2():d417-26. PubMed ID: 9281303
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle-dependent modifications in activities of pRb-related tumor suppressors and proliferation-specific CDP/cut homeodomain factors in murine hematopoietic progenitor cells.
van Wijnen AJ; Cooper C; Odgren P; Aziz F; De Luca A; Shakoori RA; Giordano A; Quesenberry PJ; Lian JB; Stein GS; Stein JL
J Cell Biochem; 1997 Sep; 66(4):512-23. PubMed ID: 9282329
[TBL] [Abstract][Full Text] [Related]
36. Decreased topoisomerase IIα expression and altered histone and regulatory factors of topoisomerase IIα promoter in patients with chronic benzene poisoning.
Yu K; Shi YF; Yang KY; Zhuang Y; Zhu RH; Xu X; Cai G
Toxicol Lett; 2011 Jun; 203(2):111-7. PubMed ID: 21382456
[TBL] [Abstract][Full Text] [Related]
37. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
[TBL] [Abstract][Full Text] [Related]
38. The retinoblastoma protein-associated cell cycle arrest in S-phase under moderate hypoxia is disrupted in cells expressing HPV18 E7 oncoprotein.
Amellem O; Sandvik JA; Stokke T; Pettersen EO
Br J Cancer; 1998 Mar; 77(6):862-72. PubMed ID: 9528826
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
Kim TA; Ravitz MJ; Wenner CE
J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288
[TBL] [Abstract][Full Text] [Related]
40. Anisomycin suppresses Jurkat T cell growth by the cell cycle-regulating proteins.
Yu C; Xing F; Tang Z; Bronner C; Lu X; Di J; Zeng S; Liu J
Pharmacol Rep; 2013; 65(2):435-44. PubMed ID: 23744428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
